Business Wire

Alkegen Launching Trio of New High Efficiency Filtration Products for Air, Liquid and Molecular Applications

Share

Alkegen, a leading specialty materials platform that provides high performance materials used in advanced applications, announced they will be launching three new High Efficiency Filtration (HEF) products during their exhibition at the upcoming World Filtration Congress in San Diego, CA. These are the first new filtration products launched under the Alkegen brand name since the merger of Lydall and Unifrax last October.

“This trio of HEF media – one for air, one for liquid, one for molecular applications – represents the first wave of advanced materials developed and released under our new Alkegen filtration product development team. These launches combine Lydall’s well-known filtration and manufacturing expertise with Unifrax’s proven, rapid innovation capabilities,” said Paul Vallis, President of the Filtration & Catalysis Group. “This is the first of many innovations we expect to deliver as our portfolio evolves to meet the continuous demand for ever-higher efficiency and reduced energy consumption.”

TriboStatiX™

Alkegen’s new air filtration media, TriboStatiX™, is a MERV 13 high performance pleat media manufactured on a new best-in-class asset. The media provides lower initial resistance, reducing the amount of energy required in the HVAC unit and lowering overall operating costs. TriboStatiX™ improves indoor air quality through consistent filtration performance and high dirt holding capacity, providing longer service life and reduced energy demand.

“With TriboStatiX, customers can expect high performance with longer service life,” said John Albert Global Growth Leader. “This means changing out filters less frequently for a more sustainable solution.”

LyPore® MB

Alkegen’s new line of meltblown liquid filtration media, LyPore® MB, is designed to meet the most critical application requirements, while providing high filtration efficiency, low-pressure drop and excellent dirt holding capacity. Available in Polypropylene and PBT, single layer or composite and calendered to meet the most complex liquid filtration challenges. Chosen for such applications as food and beverage and lube oil, incorporating Lypore MB into your filter design improves filtration efficiency and extends filter life resulting in a higher performing finished filter and lower total cost for the end user.

“In addition to our expanded portfolio of available grades, our talented research and development team routinely customizes LyPore MB to meet specific customer needs,” said Aaron Frost, Growth Leader.

LydAir® GP

Alkegen’s new molecular filtration media, LydAir GP, offer superior performance with expanded capabilities. State of the art manufacturing facilitates exceptional uniformity and layering of a wide range of functional adsorbents including activated carbon and ion exchange resins. Additionally particulate filter media can be laminated in line providing a combination media for both molecular and particle filtration. LydAir GP offers 20%-30% better performance per specific gram of media, which results in higher efficiency and product performance that can be engineered to meet specific application demands.

Behzan Shoar, Platform Manager, will be presenting the Multi-sorbent Gas Absorption Media, LydAir GP at the World Filtration Congress on Saturday, October 8th, 2022.

Alkegen’s Filtration Experts will be available to discuss these innovative materials and more during the World Filtration Congress in San Diego, CA October 5 -8th in booth #101. To learn more, visit Alkegen.com

About Alkegen

Alkegen, formerly Unifrax and Lydall Inc., creates high performance specialty materials used in advanced applications including electric vehicles, energy storage, filtration, fire protection and high-temperature insulation, among many others. Alkegen products are designed with the ultimate goal of saving energy, reducing pollution, and improving safety for people, buildings and equipment by delivering on our mission of helping the world breathe easier, live greener and go further than ever before. Alkegen has 75 manufacturing facilities operating in 12 countries and employs 9,000+ employees globally. More information is available at www.alkegen.com.

About Clearlake

Clearlake Capital Group, L.P. is an investment firm founded in 2006 operating integrated businesses across private equity, credit and other related strategies. With a sector-focused approach, the firm seeks to partner with experienced management teams by providing patient, long-term capital to dynamic businesses that can benefit from Clearlake’s operational improvement approach, O.P.S.® The firm’s core target sectors are industrials, technology and consumer. Clearlake currently has approximately $30 billion of assets under management and its senior investment principals have led or co-led over 300 investments. The firm has offices in Santa Monica and Dallas. More information is available at www.clearlake.com and on Twitter @ClearlakeCap.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For Alkegen:
Kristen Weiss
Director, Marketing Communication
kweiss@alkegen.com

For Clearlake:
Jennifer Hurson
jhurson@lambert.com
845-507-0571

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Uptime Institute Launches Uptime Institute Sustainability Assessment for Digital Infrastructure16.4.2024 12:02:00 CEST | Press release

Uptime Institute today announced the launch of the comprehensive Uptime Institute Sustainability Assessment, an assessment and award service that empowers organizations to clearly assess, benchmark, and demonstrate the sustainability credentials of their digital infrastructure to all their stakeholders, whether their applications are deployed in their own enterprise-operated data centers, as well as colocation data centers, or hosted by other third-parties such as hyperscalers or managed service providers. Organizations that undertake the Uptime Institute Sustainability Assessment will be able to develop a clear view of their sustainability status and achievements to date across a wide range of independent and interdependent corporate functions and criteria, and then monitor and demonstrate progress over time, both internally and externally. The insights gained from the Assessment can be used to make continuous improvements in support of sustainability commitments while allowing partic

TradeSun Announces an Agreement With Wells Fargo16.4.2024 12:00:00 CEST | Press release

TradeSun and Wells Fargo have entered into an agreement that will enable Wells Fargo to leverage the industry leading trade finance and compliance digitization solution from TradeSun, using Artificial Intelligence (AI) and other advanced technologies to streamline the complex and manual processes employed globally within the banking industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240415969647/en/ TradeSun’s major new release is reinventing trade finance digitalization as it breaks new ground in the world of cognitive data capture and intelligent process automation and takes compliance screening and document checking to new levels. TradeSun’s trade-focused AI will help deliver Wells Fargo’s goals by automating manual processes that will increase capacity to drive new business. Wells Fargo will utilize the TradeSun AI platform to digitize, extract, validate, and classify unstructured data for use with compliance and d

Mundipharma and Vectura announce plans to reformulate flutiform ® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint16.4.2024 11:00:00 CEST | Press release

Mundipharma and Vectura will now progress development of the reformulation of flutiform® (fluticasone propionate/formoterol fumarate) following long-term collaboration, planning and lab-scale development work. The reformulation will ultimately ensure a comparable effective product for patients and further reduce its impact on the environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416962162/en/ The productis an established pressurised metered-dose inhaler (pMDI) for the treatment of asthma, where the use of a combination product is appropriate, and has been available on the market for more than a decade.3 It currently uses the approved apaflurane hydrofluoroalkane 227 (HFA-227), a type of fluorinated greenhouse gas, as its propellant.3 European Union regulation on these types of gases aims to reduce their use, and therefore their emissions, by two-thirds by 2030.1 Work is already under way to source an alternative

Caranx Medical announces successful world first robotic assisted transcatheter heart valve implantation in an animal16.4.2024 10:30:00 CEST | Press release

Caranx Medical (‘Caranx’), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal. The assisted heart valve implantation in the animal was successfully performed by Dr. Stéphane Lopez, Caranx CMO Dr. Eric Sejor, Caranx CTO Pierre Berthet-Rayne and Caranx team. “This groundbreaking achievement is the result of hard teamwork. At Caranx Medical, we are dedicated to improving patients' lives through true innovation. This successful transcatheter robotic aortic valve implantation marks the first step toward a new generation of intelligent robots guided by AI, set to transform healthcare as we know it” says Pierre Berthet-Rayne, PhD, co-founder and CTO of Caranx. “This major medical first lies not only in the technical achievement of Caranx Medical's engine

Arthur D. Little Publishes Human After All – Latest Edition of PRISM Magazine16.4.2024 10:00:00 CEST | Press release

Arthur D. Little (ADL) has published Human After All – the latest edition of its strategy and innovation magazine PRISM. As we enter the era of AI, the first edition of 2024 highlights the importance of taking a human-centric approach to business management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416226137/en/ Arthur D. Little has published Human After All – the latest edition of its strategy and innovation magazine PRISM. (Graphic: Business Wire) The magazine features seven key articles: Optimistic global CEOs focus on people and skills in an AI future - Our lead article shares highlights from the ADL 2024 CEO Insights Study, finding that CEOs are increasingly confident of future economic success. The people-centric lab of the future – how technology and AI can play a key role in driving breakthrough innovation by enabling people to become perfect innovators. The future workforce - Recruiting and retaining vital

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye